LifeStance Health GroupLFST +2.22%57 EV-to-OCF is 21.65 as of Jun. 25, 2026, which is 50% below its 10-year median of 43.62. GuruFocus rates LFST with a GF Score™ of 57/100 and a GF Value™ of $8.22 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 686 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 80.32% on this metric.
The historical rank and industry rank for LifeStance Health Group's EV-to-OCF or its related term are showing as below:
LFST'
s EV-to-OCF Range Over the Past 10 Years
Min: -899.45 Med: 43.62 Max: 1500.66
Current: 21.65
During the past 7 years, the highest EV-to-OCF of LifeStance Health Group was 1500.66. The lowest was -899.45. And the median was 43.62.
LFST's EV-to-OCF is ranked worse than 80.32% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 8.47
vs LFST: 21.65
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
LifeStance Health Group (NAS:LFST) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
LifeStance Health Group's PE Ratio (TTM) for today is calculated as:
LifeStance Health Group's share price for today is $9.65.
LifeStance Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LifeStance Health Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's EV-to-OCF falls into.
LifeStance Health Group's current Enterprise Value is $3,949 Mil.
LifeStance Health Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $182 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a EV-to-OCF of 21.65 as of Jun. 25, 2026. This is 50% below median its historical median of 43.62. According to the industry distribution chart, LifeStance Health Group ranks #551 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 80.3%.
Is LifeStance Health Group's EV-to-OCF too high?
LifeStance Health Group's current EV-to-OCF of 21.65 is 50% below median its 10-year median of 43.62. The Healthcare Providers & Services industry median EV-to-OCF is 8.47. LifeStance Health Group's value of 21.65 is 155.6% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #551 out of 686 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LifeStance Health Group has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's EV-to-OCF compare to NHC and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #551 out of 686 companies for EV-to-OCF. This places LifeStance Health Group in the lower half of its industry. The industry median EV-to-OCF is 8.47. LifeStance Health Group's value of 21.65 is 155.6% above this benchmark. While the company's 10-year median is 43.62 vs. the industry median of 8.47, LifeStance Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.47, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current EV-to-OCF of 21.65 is 155.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current EV-to-OCF is 21.65, which is 50% below median its own 10-year median of 43.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.22, compared to a current price of $9.65 — trading 17.4% above its estimated fair value. The current EV-to-OCF is 21.65, which is 50% below median its 10-year median of 43.62 and 155.6% above the Healthcare Providers & Services industry median of 8.47. LifeStance Health Group's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current EV-to-OCF is 21.65 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $9.65 is trading 17.4% above its estimated GF Value™ of $8.22.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
EV-to-OCF: 21.65 (50% below median its 10-year median of 43.62)
GF Value™: $8.22 vs. price of $9.65 (17.4% above fair value)
Industry Position: 155.6% above the Healthcare Providers & Services median (#551 of 686)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
57GF Score
Get the complete analysis for LFST
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
